Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE008068 |
YEM_ID: | YEM-417 |
YNS_ID: | YNS-271 |
ID: | TCMBANKHE008068/YNS-271/YEM-417 |
植物拉丁名: |
|
功能与主治: | 活血止痛，软坚散结，止咳化痰。用于胃脘疼痛，肠胃溃疡，感冒咳嗽，风湿关节疼痛，癓瘕积聚，外伤肿痛|To clear heat and resolve toxin, dispel wind and eliminate damp, dissipate stasis and relieve pain./Diphtheria, swelling pain in throat, wind-damp impediment pain, knocks and falls, stomachache, swollen welling abscess and sore toxin, poisonous snake bites, rabid dog bite. |
药用植物名: | 开口箭 |
药名: | 心不干 |
来源: | 云南药材标准：第二册|云南民族药物志：第二卷 |
药用部位: | rhizome|干燥根茎 |
使用民族: | 哈尼族/拉祜族/苗族/瑶族/彝族/壮族 |
科: | 百合科 |
属: | 开口箭属 |
TCM_ID_id: | 1090 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000817 | isopolyphyllin Ⅵ | ||||
| TCMBANKIN000841 | tupistroside J | ||||
| TCMBANKIN001207 | sarmentogenin-3-O-β-D-glucopyranosyl(1→2)-α-L-rhamnopyranoside | ||||
| TCMBANKIN002401 | (25S)-spirost-5-en-3β-y-0-β-D-glucopyranosyl-(1→4)-0-α-L-rhamnopyranosyl-(l→3)]-β-D-glucopyranoside | ||||
| TCMBANKIN003034 | 25(S)-5β-1β | ||||
| TCMBANKIN003279 | tupistroside G | ||||
| TCMBANKIN003567 | upistroside I | ||||
| TCMBANKIN003696 | digitoxigenin-3-O-α-L-fucopyranose | ||||
| TCMBANKIN006498 | (25r)-26-o-β-d-glucopyranosyl-22-hydroxy-5β-furostane-3β,26-diol 3-o-β-d-glucopyra-nosyl-(1→2)-o-β-d-galactopyranoside | C45H76O19 | |||
| TCMBANKIN007929 | 25(27)-ene-1β,3β-diol-spirost-3-O-β-D-glucopyranoside | ||||
| TCMBANKIN008606 | 3-epi-neoruscogenin-3-β-D-glucopyranoside | ||||
| TCMBANKIN009084 | (2R,3R)-3,4′-dihydroxy-7-methoxyflavane | ||||
| TCMBANKIN009509 | tupistroside H | ||||
| TCMBANKIN009563 | octadecanoic acid,8,10-dimethoxy | C20H40O4 | 344.5 g/mol | CCCCCCCCC(CC(CCCCCCC(=O)O)OC)OC | |
| TCMBANKIN010651 | convallagenin B | C27H44O6 | 464.6 g/mol | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6(C5(C(CC(C6O)O)O)C)O)C)C)OC1 | |
| TCMBANKIN010673 | tupichiside A | ||||
| TCMBANKIN012040 | (25S)-1β,3β,22α,26-tetraol-furost-26-O-β-D-glucopyranoside | ||||
| TCMBANKIN012647 | octadecanoic acid,8,10-dimethoxyl | ||||
| TCMBANKIN014373 | (25S)-5(6)-ene-3β,4β,7α-triolspirost | ||||
| TCMBANKIN014512 | (25S)-1β,3β,24β-triolspirost | ||||
| TCMBANKIN015061 | iso-epiruscogenin | ||||
| TCMBANKIN016296 | ranmogenin A | C27H42O6 | 462.6 g/mol | CC1C2C(CC3C2(CCC4C3CCC5(C4(C(CC(C5O)O)O)C)O)C)OC16CCC(=C)CO6 | |
| TCMBANKIN016652 | tupichigenin-5-O-β-D-glucopyranoside | ||||
| TCMBANKIN016723 | (25s)-26-[(o-β-d-glucopyranosyl-(1→6)-β-d-glucopyranosyl)oxy]-22α-methoxyfurost-5-en-3β-ylo-α-l-rhamnopyranosyl-(1→2)-o-[o-β-d-glucopyranosyl-(1→4)-α-l-rhamnopyranos-yl-(1→3)]-β-d-glucopyranoside | C64H106O32 | CC1C2C(CC3C2(CCC4C3CC=C5C4(CCC(C5)OC6C(C(C(C(O6)CO)O)OC7C(C(C(C(O7)C)OC8C(C(C(C(O8)CO)O)O)O)O)O)OC9C(C(C(C(O9)C)O)O)O)C)C)OC1(CCC(C)COC1C(C(C(C(O1)COC1C(C(C(C(O1)CO)O)O)O)O)O)O)OC | ||
| TCMBANKIN016736 | oleandrigenin-3-O-β-D-glucopyranosyl(1→2)-α-Lrhamnopyranoside | ||||
| TCMBANKIN018621 | glucodigifucoside | C35H54O13 | 682.8 g/mol | CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)C)O)O)OC7C(C(C(C(O7)CO)O)O)O | |
| TCMBANKIN019032 | 2-［5-(2-furanyl)pyrazolyl］-5-methyl-phenol | ||||
| TCMBANKIN020488 | polyphyllin Ⅵ | ||||
| TCMBANKIN020677 | 6-methylalizarin | C15H10O4 | CC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C=CC(=C3O)O | ||
| TCMBANKIN020709 | 3'-hydroxy-4--methoxyisoflavone-7-o-beta-d-glucoside | ||||
| TCMBANKIN022232 | digitoxigenin-3-O-β-D-glucopyranosyl-(1-4)-α-L-digitoxopyranosyl | ||||
| TCMBANKIN024591 | 8-methylluteolin | C28H32O15 | CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC(=C(C=C5)O)OC)O)CO)O)O)O)O)O | ||
| TCMBANKIN024920 | octadecanoic acid,9,11,13-trimethoxyl | ||||
| TCMBANKIN025005 | Isoepiruscogenin-3-O-β-D-glucopyranoside | ||||
| TCMBANKIN025716 | 1,2-bis(4-hydroxyphenyl)-cyclopentane | ||||
| TCMBANKIN025921 | tupichigenin G | ||||
| TCMBANKIN026789 | 3-epi-ruscogenin-3-β-D-glucopyranoside | ||||
| TCMBANKIN028091 | 4,4'-dihydroxychalcone | C15H12O3 | 240.25 g/mol | C1=CC(=CC=C1C=CC(=O)C2=CC=C(C=C2)O)O | |
| TCMBANKIN028651 | tupichigenin H | ||||
| TCMBANKIN028855 | 5-ene-methyl-7,12-didehydroxy-cholate-3-o-α-l-rhamnopyranosyl-(1→4)-β-d-glucurono-pyranoside | C37H58O13 | CC1C(C(C(C(O1)OC2C(C(C(OC2C(=O)O)OC3CCC4(C5CCC6(C(C5CC=C4C3)CCC6C(C)CCC(=O)OC)C)C)O)O)O)O)O | ||
| TCMBANKIN029071 | tupichigenin I | ||||
| TCMBANKIN029848 | spirost-25(27)-ene-1β,2β,3β,4β,5β,6β,7α-heptol | ||||
| TCMBANKIN030016 | (24s,25s)-24-[(β-d-glucopyranosyl)oxy]-2α-hydroxyspirost-5-en-3β-yl o-β-d-glucopyra-nosyl-(1→3)-o-β-d-glucopyranosyl-(1→2)-o-[β-d-xylopyranosyl-(1→3)]-o-β-d-gluco-pyranosyl-(1→4)-β-d-galactopyranoside | C62H100O34 | CC1COC2(CC1OC3C(C(C(C(O3)CO)O)O)O)C(C4C(O2)CC5C4(CCC6C5CC=C7C6(CC(C(C7)OC8C(C(C(C(O8)CO)OC9C(C(C(C(O9)CO)O)OC1C(C(C(CO1)O)O)O)OC1C(C(C(C(O1)CO)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)O)O)C)C)C | ||
| TCMBANKIN030463 | wattigenin B | ||||
| TCMBANKIN032017 | allylpyrocatechol | C9H10O2 | 150.17 g/mol | C=CCC1=C(C(=CC=C1)O)O | |
| TCMBANKIN032826 | convallagenin A | C27H44O5 | 448.6 g/mol | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6(C5(C(CC(C6)O)O)C)O)C)C)OC1 | |
| TCMBANKIN034645 | octadecanoic acid,9,10,12-trimethoxyl | ||||
| TCMBANKIN035553 | (2R)-7,4′-dihydroxy-8-methylflavane | ||||
| TCMBANKIN035995 | epiruscogenin-3-O-β-D-glucopyranoside | ||||
| TCMBANKIN036990 | (25s)-1β,3β,4β-trihydroxyspirostan-5β-yl-o-β-d-glucopyranoside | C33H54O11 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6(C5(C(CC(C6O)O)O)C)OC7C(C(C(C(O7)CO)O)O)O)C)C)OC1 | ||
| TCMBANKIN041780 | trans-Methyl p-coumarate | ||||
| TCMBANKIN042604 | 3-epioleanolic acid | chikusetsu saponin V_qt; 3-epi-oleanolic acid; oleanolic acid 3-O-[β-D-glucuronopyranoside-6-O-butyl ester]-28-O-β-D-glucopyranoside_qt; chikusetsusaponin,iva_qt; 3-epioleanolicacid; oleanolic acid 3-O-[β-D-glucuronopyranoside-6-O-methyl ester]-28-O-β-D-glucopyranoside_qt; oleanolic acid 3-O-[β-D-glucuronopyranoside-6-O-ethyl ester]-28-O-β-D-glucopyranoside_qt | C30H48O3 | 457 | C([H])([H])([H])C1(C([H])([H])[H])C([H])([H])[C@@]([H])(C(=C([H])C([H])([H])[C@@]2([H])[C@@]3(C([H])([H])[H])C([H])([H])C([H])([H])[C@]4([H])[C@]2(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]([H])(O[H]) C4(C([H])([H])[H])C([H])([H])[H])[C@@]3(C([H])([H])[H])C([H])([H])C5([H])[H])[C@]5(C(O[H])=O)C([H])([H])C1([H])[H] |
| TCMBANKIN042967 | Tupichinol B | 316.3 g/mol | |||
| TCMBANKIN043440 | Tupichigenin F | 464.6 g/mol | |||
| TCMBANKIN043637 | Δ25(27)-pentrogenin | C27H42O7 | CC1C2C(CC3C2(CCC4C3CCC5(C4(C(C(C(C5O)O)O)O)C)O)C)OC16CCC(=C)CO6 | ||
| TCMBANKIN043832 | p-hydroxybenzaldehyde | p-hydroxybenz-aldehyde; 298704-22-0; p- hydroxybenzaldehyde; SCHEMBL13804892; p-hydroxy benzaldehyde; 4-hydroxy-[2,3,5,6,7-2H5]-benzaldehyde; p-hydroxy-benzaldehyde; p-HBAld | C7H6O2 | 127.15 g/mol | C1=CC(=CC=C1C=O)O |
| TCMBANKIN044026 | (25s)-inokosterone | C27H44O7 | 480.6 g/mol | CC(CCC(C(C)(C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)O)O)CO | |
| TCMBANKIN044103 | 3-Epischelhammericine | 313.4 g/mol | |||
| TCMBANKIN044321 | Rhodeasapogenin-3-O-β-D-glucopyranoside | ||||
| TCMBANKIN045382 | tupipregnenolone | C21H30O3 | 330.5 g/mol | CC(=O)C1=CCC2C1(CCC3C2CC=C4C3(C(CC(C4)O)O)C)C | |
| TCMBANKIN047282 | tupichigenin d | C27H42O6 | 462.6 g/mol | CC1C2C(CC3C2(CCC4C3CCC5(C4(C(CC(C5O)O)O)C)O)C)OC16CCC(=C)CO6 | |
| TCMBANKIN047720 | tupichigenin e | C27H42O5 | 446.6 g/mol | CC1C2C(CC3C2(CCC4C3CCC5(C4(C(CC(C5)O)O)C)O)C)OC16CCC(=C)CO6 | |
| TCMBANKIN047806 | Isorhodeasapogenin-3-O-β-D-glucopyranoside | ||||
| TCMBANKIN047957 | 4-Epi-11-nor-aristola-1(10),11-diene | 188.31 g/mol | |||
| TCMBANKIN048670 | Tupichinol C | 242.27 g/mol | |||
| TCMBANKIN048775 | tupichinol a | C17H18O4 | 286.32 g/mol | CC1=C(C=CC2=C1OC(C(C2)O)C3=CC=C(C=C3)O)OC | |
| TCMBANKIN049756 | pentologenin | C27H44O7 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6(C5(C(C(C(C6O)O)O)O)C)O)C)C)OC1 | ||
| TCMBANKIN058149 | isoluteolin | orobol; 5,7,3 ', 4'-tetrahydroxy isoflavone; Santol | C15H10O6 | 286.24 g/mol | C1=CC(=C(C=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O)O |
| TCMBANKIN058192 | isoliquiritigenin | HCC; KBio2_000625; SPBio_000949; Spectrum2_000875; 961-29-5; 2-PROPEN-1-ONE, 1-(2,4-DIHYDROXYPHENYL)-3-(4-HYDROXYPHENYL)-; SPECTRUM1504200; Chalcone, 2',4,4'-trihydroxy-; CHEMBL1395334; KBio3_002631; NCGC00015556-01; SDCCGMLS-0066751.P001; ST5309279; (2E)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one; KBio2_003193; InChI=1/C15H12O4/c16-11-4-1-10(2-5-11)3-8-14(18)13-7-6-12(17)9-15(13)19/h1-9,16-17,19H/b8-3; (E)-1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one; CMLD3_000056; BSPBio_003411; C08650; CCRIS 7676; 2',4,4'-Trihydroxychalcone; Lopac0_000681; 1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one; I159_SIGMA; 1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one; Lopac-I-3766; CPD-3041; KBio1_001802; MEGxp0_001326; ZINC3869607; BRN 1914295; MLS000438943; SMR000112969; Acrylophenone, 2',4'-dihydroxy-3-(p-hydroxyphenyl)-; (2E)-1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one; ACon1_000047; GU 17; KBioGR_002232; DivK1c_006858; KBio2_005761; 1-08-00-00707 (Beilstein Handbook Reference); 4,2′,4′-Trihydroxychalcone; (E)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one; NCGC00090504-01; (Z)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one; EU-0100681; Spectrum3_001656; AC1O7G44; 4,2',4'-Trihydroxychalcone; EINECS 237-316-5; I3766_SIGMA; AIDS035379; AIDS-035379; 13745-20-5; Spectrum5_000612; 2-propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)-, (2E)-; Spectrum_000145; KBioSS_000625; Isoliquiritigenin; Spectrum4_001756; 42'4'-trihydroxychalcone; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)-, (E)-; NCGC00090504-03; SpecPlus_000762; 2',4',4-trihydroxychalcone | C15H12O4 | 256.25 g/mol | C1=CC(=CC=C1C=CC(=O)C2=C(C=C(C=C2)O)O)O |
| TCMBANKIN060096 | digitoxigenin | C23H34O4 | 374.5 g/mol | CC12CCC(CC1CCC3C2CCC4(C3(CCC4C5=CC(=O)OC5)O)C)O | |
| TCMBANKIN060249 | sarmentogenin-3-O-α-L-rhamnopyranoside | C29H44O9 | 536.7 g/mol | CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3C(CC5(C4(CCC5C6=CC(=O)OC6)O)C)O)C)O)O)O | |
| TCMBANKIN060349 | 25(27)-ene-1β,2β,3β,4β,5β,7α-hexaol-spirost-6-one | C27H40O8 | CC1C2C(CC3C2(CCC4C3CC(=O)C5(C4(C(C(C(C5O)O)O)O)C)O)C)OC16CCC(=C)CO6 | ||
| TCMBANKIN060350 | (25s)-1β-[(β-d-glucopyranosyl)oxy]-6β-hy-droxy-22α-methoxy-3α,5α-cyclofurostan-26-ylβ-d-glucopyranoside;(25s)-1β-[(β-d-fucopyranosyl)oxy]-6β-hydroxy-22α-methoxy-3α,5α-cyclofurostan-26-ylβ-d-glucopyranoside | C40H66O15 | CC1C2C(CC3C2(CCC4C3CC(C56C4(C(CC5C6)OC7C(C(C(C(O7)CO)O)O)O)C)O)C)OC1(CCC(C)COC8C(C(C(C(O8)CO)O)O)O)OC | ||
| TCMBANKIN060399 | (25r)-5α-spirostan-3β,6α,23α-triol-6-o-β-d-glucopyranoside | C39H64O15 | CC1CC(C2(C(C3C(O2)CC4C3(CCC5C4CC(C6C5(CCC(C6)OC7C(C(C(C(O7)CO)O)O)O)C)OC8C(C(C(C(O8)CO)O)O)O)C)C)OC1)O | ||
| TCMBANKIN060487 | epiruscogenin | C27H42O4 | 430.6 g/mol | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(C(CC(C6)O)O)C)C)C)OC1 | |
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060693 | Sitogluside | C35H60O6 | 576.85g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN061091 | stearic acid | CH3(CH2)16COOH | 284.5 g/mol | CCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061134 | Hexacosanoic acid | C26H52O2 | 396.7 g/mol | CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061403 | Abiol | AIDS209944; Methyl Parasept; H3647_SIGMA; Methyl p-hydroxybenzoate; BRN 0509801; FEMA Number 2710; p-Methoxycarbonylphenol; 4-HYDROXY-BENZOIC ACID METHYL ESTER; Benzoic acid, p-hydroxy-, methyl ester; Nipagin M; 4-Hydroxybenzoic acid, methyl ester; Nipagin; p-Oxybenzoesauremethylester [German]; D01400; Methyl chemosept; p-Hydroxybenzoic methyl ester; 4-(Methoxycarbonyl)phenol; Tegosept M; 4-10-00-00360 (Beilstein Handbook Reference); Aseptoform; H6654_SIAL; Methyl 4-hydroxybenzoate; Maseptol; BENZOIC ACID,4-HYDROXY,METHYL ESTER; AI3-01336; NCGC00159376-02; Methylparaben (TN); Metaben; Methyl-p-hydroxybenzoate; 99-76-3; Preserval M; Methylparaben (NF); Methyl parahydroxybenzoate (JP15); ST5214511; p-Hydroxybenzoic acid methyl ester; CCRIS 3946; Methyl ester of p-hydroxybenzoic acid; Methylparaben; p-Hydroxybenzoic acid, methyl ester; Caswell No. 573PP; FEMA No. 2710; NCGC00159376-03; p-Carbomethoxyphenol; Methylben; 47889_SUPELCO; NSC3827; ZINC00001712; AIDS-209944; Preserval; HSDB 1184; Metoxyde; Methaben; Moldex; WLN: QR DVO1; 4-Hydroxybenzoic acid methyl ester; InChI=1/C8H8O3/c1-11-8(10)6-2-4-7(9)5-3-6/h2-5,9H,1H; Solbrol M; Methylparaben [USAN]; 54752_FLUKA; Benzoic acid, 4-hydroxy-, methyl ester; Methyl parahydroxybenzoate; component of Heb-Cort MC; 54750_FLUKA; NSC406127; Methyl Butex; Solbrol; Methyl paraben; Paridol; EINECS 202-785-7; M8911_SIAL; Methyl p-oxybenzoate; NSC 3827; W271004_ALDRICH; EPA Pesticide Chemical Code 061201; Methyl parahydroxybenzoate (TN); Methylester kyseliny p-hydroxybenzoove [Czech]; Septos; methyl p-hydroxybenzoate; 4-hydroxybenzoic acid methyl ester; methyl-4-hydroxybenzoate; Methyl paraben; methylparaben | C8H8O3 | 152.15 g/mol | COC(=O)C1=CC=C(C=C1)O |
| TCMBANKIN061561 | vanillic acid | CJ-02984; CHEBI:16632; Vanillate; CHEBI:30816; H36001_ALDRICH; InChI=1/C8H8O4/c1-12-7-4-5(8(10)11)2-3-6(7)9/h2-4,9H,1H3,(H,10,11; BRN 2208364; WKOLLVMJNQIZCI-UHFFFAOYSA-M; 94770_FLUKA; WLN: QVR DQ CO1; MLS000574833; Acide vanillique; vanillicacid; C06672; m-Anisic acid, 4-hydroxy-; VA (VAN); vanil-lic acid; 4-Hydroxy-3-methoxybenzoic acidion; 4-Hydroxy-3-methoxybenzoic acid; Protocatechuic acid, 3-methyl ester; NSC3987; NSC 674322; DB02130; VANILLIC ACID; p-Vanillic acid; NSC 3987; ZB010900; 4-Hydroxy-3-methoxybenzoate; AIDS-018089; p-Hydroxy-m-methoxy-benzonic acid; 3-Methoxy-4-hydroxybenzoic acid; 4-hydroxy-3-methoxy-benzoic acid; NSC674322; 6746-48-1; 121-34-6; AC1L2LVA; Benzoic acid, 4-hydroxy-3-methoxy-; AI3-19542; SMR000156289; AIDS018089; SBB008280; W398802_ALDRICH; EINECS 204-466-8; 4-hydroxy-3-methoxy benzoic acid; 3-methoxy-4-hydroxybenzoic acid | C8H8O4 | 168.15 g/mol | COC1=C(C=CC(=C1)C(=O)O)O |
| TCMBANKIN061745 | syringic acid; Syryngic; 1,5-dimethoxy-3-hydroxybenzoicacid; 3,5-dimethoxy-4-hydroxybenzoic acid; Cedar acid | I01-1212; syringicacid; 3,5-dimethoxy-4-oxidanyl-benzoate; CHEBI:132111; 4-hydroxy-3,5-dimethoxybenzoate; c1409; ZB006317; AKOS015888648; A824548; A829374; CJ-01507; AC1OC351; ST51051575; C10833; DivK1c_006581; KBio3_002814; 530-57-4; AI3-24376; 3,5-Dimethoxy-4-hydroxybenzyl acid; S6881_SIGMA; BSPBio_003312; InChI=1/C9H10O5/c1-13-6-3-5(9(11)12)4-7(14-2)8(6)10/h3-4,10H,1-2H3,(H,11,12; EINECS 208-486-8; Gallic acid 3,5-dimethyl ether; Syringic acid; NSC2129; Spectrum3_001866; 4-10-00-01995 (Beilstein Handbook Reference); 4-Hydroxy-3,5-dimethoxybenzoic acid; SpecPlus_000485; NSC 2129; 4-hydroxy-3,5-dimethoxy-benzoic acid; Spectrum5_000963; ST5214746; KBio1_001525; BRN 2115262; 3,5-Dimethoxy-4-hydroxybenzoic acid; Benzoic acid, 4-hydroxy-3,5-dimethoxy- | C9H10O5 | 198.17 g/mol | COC1=CC(=CC(=C1O)OC)C(=O)O |
| TCMBANKIN061762 | syringaresinol | (+)-Suyringaresinol-di-O-beta-D-glucoside_qt; (+)syringaresinol; (+)-Suyringaresinol-di-O-beta-D-glucoside; liriodendrin_qt; dl-Syringaresinol; syringaresinol diglucoside_qt; dl-sy-ringaresinol; (+)-syringaresinol-O-β-D-glucopyranoside; (+ )-syringaresinol; 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxy-phenol; 21453-69-0; C10889; (7alpha,7'alpha,8alpha,8'alpha)-3,3',5,5'-tetramethoxy-7,9':7',9-diepoxylignane-4,4'-diol; CHEBI:47; 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxyphenol; (+)-syringaresinol; (+ )- syringaresinol; dl-syringaresinol; (-)-syringaresinol; episyringaresinol; (+)-syringarosinol; (+ )-Syringaresinol-O-β-D-glucopyranoside; syringaresino; (-)-syringaresinol; (?)-syringaresinol; (+)-Syringaresinol; lirioresinol-A | C34H46O18 | 742.72 | COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)O)OC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab